Construction Materials

SHANSHUI CEMENT

SHANSHUI CEMENT released FY2026 Q1 earnings on April 30 (BJT), actual revenue HKD 1.333 B, actual EPS HKD 0

Shanshui Cement released FY2025 9 Months Earnings on March 4, 2026 (BJT) with actual revenue of HKD 9.297 B and EPS of HKD -0.1578

SHANSHUI CEMENT released FY2025 Q3 earnings on March 4, 2026 (BJT), actual revenue HKD 3.283 B, actual EPS HKD -0.0929

SHANSHUI CEMENT released FY2025 earnings on March 4 During-Market (BJT), actual revenue HKD 12.64 B, actual EPS HKD -0.2513

SHANSHUI CEMENT released FY2025 Q4 earnings on March 4 During-Market (BJT), actual revenue HKD 3.34 B, actual EPS HKD -0.0945

SHANSHUI CEMENT to Release FY2025 Earnings Report on March 4, 2026 During-Market BJT

SHANSHUI CEMENT released FY2025 Q1 earnings on August 11, 2025 (BJT), actual revenue HKD 1.736 B, actual EPS HKD 0

Shanshui Cement released FY2025 Q2 earnings on August 11 During-Market (BJT), actual revenue HKD 3.039 B, actual EPS HKD -0.0328

Shanshui Cement released FY2025 Semi-Annual Earnings on August 11 During-Market (BJT), Actual Revenue: HKD 6.013 B, Actual EPS: HKD -0.0649

SHANSHUI CEMENT to Release FY2025 Semi-Annual Earnings on August 11, 2025 (BJT)

Sinograin Cement Q1 2025 Loss Narrowed

Shanshui Cement released FY2024 Q3 earnings on March 12 (BJT) with actual revenue of 4.402 B HKD and EPS of 0.0496 HKD

SHANSHUI CEMENT released FY2024 9 Months Earnings on March 12 (BJT), with actual revenue of 11.49 B HKD and EPS of -0.0818 HKD

Shanshui Cement released FY2024 Q4 earnings on March 12 After-Market (BJT), actual revenue 4.225 B HKD, actual EPS 0.0476 HKD

Shanshui Cement released FY2024 annual earnings on March 12 After-Market (BJT), actual revenue 15.71 B HKD, actual EPS -0.0349 HKD

Shanshui Cement to Release FY2024 Earnings on March 12 After-Market BJT

Shanshui Cement releases nine-month performance as of September 30, 2024

Shanshui Cement appoints Teng Yongjun as Chairman and Executive Director

Shanshui Cement releases interim performance for the six months ended June 30, 2024

Shanshui Cement Board of Directors Changes Announcement

HINSANG GROUP

RIVERINE CHINA

PASHUN INT RTS

BRAINAURORA-B

SOFTMEDX

GOLDENPOWER

ZHONGKE GROUP

VISION SYNERGY

GEMILANG INTL

GHPC

00691

China Shanshui Cement Group reported a significant quarterly loss for the period ending March 31, 2026, with operating revenue dropping to RMB1.18 billion from RMB1.62 billion year-on-year. The company's net assets decreased to RMB16.31 billion, and the operating loss widened to RMB742.6 million due to higher administrative expenses and weaker gross profit. The net loss reached RMB787.0 million, highlighting ongoing financial challenges in a tough cement market.

Tip Ranks

China Shanshui Cement Widens Quarterly Loss as Revenue Falls and Costs Stay High

00743

Asia Cement (China) Holdings is seeking shareholder approval to extend and increase connected supply agreements with related parties until 2028. The agreements involve revising annual caps for sales and purchases of clinker, cement, and slag powder for 2026. Due to the size of these transactions, independent shareholders' approval is required at an extraordinary general meeting. The company aims to ensure that the extended arrangements are on normal commercial terms and in the interests of all shareholders. Asia Cement holds approximately 73% of the company and controls related subsidiaries.

ASIA CEMENT CH

Asia Cement (China) Seeks Shareholder Approval to Extend and Upsize Connected Supply Deals to 2028

China Shanshui Cement Group reported a significant revenue decline of 20.3% in 2025, totaling approximately RMB11.56 billion, leading to an operational loss of RMB518 million. The loss attributable to equity shareholders increased sharply to around RMB983 million, with a basic loss per share of RMB0.23. The company faces challenges due to weaker demand, pricing pressures, and elevated costs, impacting its financial performance and investor sentiment. The latest analyst rating for the stock (HK:0691) is a Hold, with a price target of HK$0.52.

China Shanshui Cement Swings to Deep Loss on Revenue Slump in 2025

According to the Zhitong Finance APP, SHANSHUI CEMENT announced that for the nine months ending September 30, 2025, it achieved operating revenue of 8.946 billion yuan, a year-on-year decrease of 17.99%; the loss attributable to shareholders was 132 million yuan, a year-on-year increase of 12.47%

Zhitong

SHANSHUI CEMENT released its performance for the first three quarters, with a loss attributable to shareholders of 132 million yuan, an increase of 12.47% year-on-year

China Shanshui Cement Group (HK:0691) reported a financial decline for the nine months ending September 30, 2025, with operating revenue decreasing and a loss before taxation of RMB 121,997,000. Increased finance costs and reduced net revenue have impacted profitability, potentially affecting market positioning and stakeholder confidence. The latest analyst rating for the stock is a Hold, with a price target of HK$0.50. The company focuses on cement production and serves infrastructure and construction markets, with a current market cap of HK$3.57B.

China Shanshui Cement Reports Financial Decline for Nine Months Ending September 2025

Shanshui Cement fell 12.24%; China National Building Material fell 0.93%, with a transaction amount of HKD 72.22 million; Western Cement rose 3.29%, with a transaction amount of HKD 60.55 million; Conch Cement rose 1.31%, with a transaction amount of HKD 47.1 million; Huaxin Cement rose 2.43%, with a market value of HKD 30.7 billion

HK Stock Alerts

Hong Kong Stock Movement: SHANSHUI CEMENT fell 12.24%

300194

The Asian market is attracting attention as investors focus on penny stocks amid changing trade policies and monetary adjustments. Notable penny stocks include K. Wah International Holdings, China Shanshui Cement Group, and Fuan Pharmaceutical (Group), each with varying market caps and financial health ratings. K. Wah has a market cap of HK$7.79 billion but faces declining earnings. China Shanshui, with a market cap of HK$3.83 billion, has seen volatile prices and a recent net loss. Fuan Pharmaceutical, valued at CN¥5.85 billion, shows operational resilience despite negative earnings growth.

Simplywall

Fuan Pharmaceutical

Asian Market Highlights: Penny Stocks To Watch In August 2025

SHANSHUI CEMENT(00691.HK)